Cotrimoxazole tablets

Cotrimoxazole tablets

Form: Tablets

Strength: 80 mg trimethoprim / 400 mg sulfamethoxazole

Reference Brands: Bactrim, Septra(US & EU)

Category: Transplant

Cotrimoxazole tablets, marketed as Bactrim and Septra, are approved in the US by the FDA and in the EU via EMA for treating bacterial infections including urinary tract, respiratory, and skin infections. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and worldwide availability of cotrimoxazole tablets, ensuring effective antibacterial therapy for patients across the globe.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Acyclovir tablet

Strength: 200 mg, 400 mg, 800 mg

Form: Tablets

Reference Brands: Zovirax(US & EU)

View Details Get Enquiry
Belatacept injection

Strength: 250 mg/vial

Form: Injection

Reference Brands: Nulojix(US)

View Details Get Enquiry
Basiliximab Injectable Solution

Strength: 20 mg/vial

Form: Injectable Solution

Reference Brands: Simulect(US)

View Details Get Enquiry
Prednisolone syrup

Strength: 15 mg/5ml

Form: Syrup

Reference Brands: Orapred(US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.